"Designing Growth Strategies is in our DNA"

Global Anti Fungal Drugs Market Size, Share & Industry Analysis, By Drug Type (Echinocandins, Azoles, Polyenes, and Allylamines), By Indication (Dermatophytosis, Aspergillosis, Candidiasis, and Others), By Route of Administration (Oral, Topical, and Parenteral), By Distribution Channel (Hospital Pharmacies, Retails Pharmacies & Drug Stores, and Others), and Regional Forecast, 2020-2027

Last Updated: February 03, 2025 | Format: PDF | Report ID: FBI101188

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
  4. Key Insights
    1. Key Industry Developments (Mergers, Acquisitions, and Partnerships, etc.)
    2. Prevalence of Fungal Infections
    3. Pipeline Analysis
    4. New Product Launches
  5. Global Anti-Fungal Drugs Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Drug Type
      1. Azoles
      2. Echinocandins
      3. Polyenes
      4. Allylamines
    3. Market Analysis, Insights and Forecast – By Indication
      1. Dermatophytosis
      2. Candidiasis
      3. Aspergillosis
      4. Others
    4. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Topical
      3. Parenteral
    5. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospitals Pharmacies
      2. Retail Pharmacies & Drug Stores
      3. Online Pharmacies
    6. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Anti-Fungal Drugs Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis – By Drug Type
      1. Azoles
      2. Echinocandins
      3. Polyenes
      4. Allylamines
    3. Market Analysis – By Indication
      1. Dermatophytosis
      2. Candidiasis
      3. Aspergillosis
      4. Others
    4. Market Analysis – By Route of Administration
      1. Oral
      2. Topical
      3. Parenteral
    5. Market Analysis – By Distribution Channel
      1. Hospitals Pharmacies
      2. Retail Pharmacies & Drug Stores
      3. Online Pharmacies
    6. Market Analysis – By Country
      1. U.S.
      2. Canada
  7. Europe Anti-Fungal Drugs Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis – By Drug Type
      1. Azoles
      2. Echinocandins
      3. Polyenes
      4. Allylamines
    3. Market Analysis – By Indication
      1. Dermatophytosis
      2. Candidiasis
      3. Aspergillosis
      4. Others
    4. Market Analysis – By Route of Administration
      1. Oral
      2. Topical
      3. Parenteral
    5. Market Analysis – By Distribution Channel
      1. Hospitals Pharmacies
      2. Retail Pharmacies & Drug Stores
      3. Online Pharmacies
    6. Market Analysis – By Country/ sub-region
      1. U.K.
      2. Germany
      3. France
      4. Spain
      5. Italy
      6. Scandinavia
      7. Rest of Europe
  8. Asia pacific Anti-Fungal Drugs Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis – By Drug Type
      1. Azoles
      2. Echinocandins
      3. Polyenes
      4. Allylamines
    3. Market Analysis – By Indication
      1. Dermatophytosis
      2. Candidiasis
      3. Aspergillosis
      4. Others
    4. Market Analysis – By Route of Administration
      1. Oral
      2. Topical
      3. Parenteral
    5. Market Analysis – By Distribution Channel
      1. Hospitals Pharmacies
      2. Retail Pharmacies & Drug Stores
      3. Online Pharmacies
    6. Market Analysis – By Country/ sub-region
      1. Japan
      2. China
      3. India
      4. Australia
      5. Southeast Asia
      6. Rest of Asia Pacific
  9. Latin America Anti-Fungal Drugs Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis – By Drug Type
      1. Azoles
      2. Echinocandins
      3. Polyenes
      4. Allylamines
    3. Market Analysis – By Indication
      1. Dermatophytosis
      2. Candidiasis
      3. Aspergillosis
      4. Others
    4. Market Analysis – By Route of Administration
      1. Oral
      2. Topical
      3. Parenteral
    5. Market Analysis – By Distribution Channel
      1. Hospitals Pharmacies
      2. Retail Pharmacies & Drug Stores
      3. Online Pharmacies
    6. Market Analysis – By Country/ sub-region
      1. Brazil
      2. Mexico
      3. Rest of Latin America
  10. Middle East & Africa Anti-Fungal Drugs Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis – By Drug Type
      1. Azoles
      2. Echinocandins
      3. Polyenes
      4. Allylamines
    3. Market Analysis – By Indication
      1. Dermatophytosis
      2. Candidiasis
      3. Aspergillosis
      4. Others
    4. Market Analysis – By Route of Administration
      1. Oral
      2. Topical
      3. Parenteral
    5. Market Analysis – By Distribution Channel
      1. Hospitals Pharmacies
      2. Retail Pharmacies & Drug Stores
      3. Online Pharmacies
    6. Market Analysis – By Country/ sub-region
      1. GCC Countries
      2. South Africa
      3. Rest of Middle East & Africa
  11. Competitive Analysis
    1. Key Industry Developments
    2. Global Market Share Analysis (2019)
    3. Competition Dashboard
    4. Comparative Analysis – Major Players
    5. Company Profiles (Overview, Products & services, SWOT analysis, Recent developments, strategies, financials (based on availability))
      1. Astellas Pharma Inc.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      2. Merck & Co., Inc.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      3. Pfizer Inc
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      4. Leadiant Biosciences, Inc.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      5. McKesson Medical-Surgical Inc
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      6. GlaxoSmithKline plc.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      7. Novartis AG
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      8. Bayer AG
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      9. Abbott
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      10. Other Prominent Players
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
  12. Strategic Recommendations
Read Less

Figure 1:  Global Anti-Fungal Drugs Market Revenue Breakdown (US$ Bn, %) by Region, 2019 & 2026

Figure 2:  Global Anti-Fungal Drugs Market Value Share (%), by Drug Type, 2019 & 2026

Figure 3:  Global Anti-Fungal Drugs Market Forecast (US$ Bn), by Azoles, 2016-2027

Figure 4:  Global Anti-Fungal Drugs Market Forecast (US$ Bn), by Echinocandins, 2016-2027

Figure 5:  Global Anti-Fungal Drugs Market Forecast (US$ Bn), by Polyenes, 2016-2027

Figure 6:  Global Anti-Fungal Drugs Market Forecast (US$ Bn), by Allylamines, 2016-2027

Figure 7:  Global Anti-Fungal Drugs Market Value Share (%), by Indication, 2019 & 2026

Figure 8:  Global Anti-Fungal Drugs Market Forecast (US$ Bn), by Dermatophytosis, 2016-2027

Figure 9:  Global Anti-Fungal Drugs Market Forecast (US$ Bn), by Candidiasis, 2016-2027

Figure 10:  Global Anti-Fungal Drugs Market Forecast (US$ Bn), by Aspergillosis, 2016-2027

Figure 11:  Global Anti-Fungal Drugs Market Forecast (US$ Bn), by Others, 2016-2027

Figure 12:  Global Anti-Fungal Drugs Market Value Share (%), by Route of Administration, 2019 & 2026

Figure 13:  Global Anti-Fungal Drugs Market Forecast (US$ Bn), by Oral, 2016-2027

Figure 14:  Global Anti-Fungal Drugs Market Forecast (US$ Bn), by Topical, 2016-2027

Figure 15:  Global Anti-Fungal Drugs Market Forecast (US$ Bn), by Parenteral, 2016-2027

Figure 16:  Global Anti-Fungal Drugs Market Value Share (%), by Distribution Channel, 2019 & 2026

Figure 17:  Global Anti-Fungal Drugs Market Forecast (US$ Bn), by Hospitals Pharmacies, 2016-2027

Figure 18:  Global Anti-Fungal Drugs Market Forecast (US$ Bn), by Retail Pharmacies & Drug Stores, 2016-2027

Figure 19:  Global Anti-Fungal Drugs Market Forecast (US$ Bn), by Online Pharmacies, 2016-2027

Figure 20:  Global Anti-Fungal Drugs Market Value (US$ Bn), by Region, 2019 & 2026

Figure 21:  North America Anti-Fungal Drugs Market Value (US$ Bn), by Drug Type, 2019 & 2026

Figure 22:  North America Anti-Fungal Drugs Market Value Share (%), by Drug Type, 2019

Figure 23:  North America Anti-Fungal Drugs Market Value (US$ Bn), by Indication, 2019 & 2026

Figure 24:  North America Anti-Fungal Drugs Market Value Share (%), by Indication, 2019

Figure 25:  North America Anti-Fungal Drugs Market Value (US$ Bn), by Route of Administration, 2019 & 2026

Figure 26:  North America Anti-Fungal Drugs Market Value Share (%), by Route of Administration, 2019

Figure 27:  North America Anti-Fungal Drugs Market Value (US$ Bn), by Distribution Channel, 2019 & 2026

Figure 28:  North America Anti-Fungal Drugs Market Value Share (%), by Distribution Channel, 2019

Figure 29:  North America Anti-Fungal Drugs Market Value (US$ Bn), By Country, 2019 & 2026

Figure 30:  North America Anti-Fungal Drugs Market Value Share (%), By Country, 2019

Figure 31:  Europe Anti-Fungal Drugs Market Value (US$ Bn), by Drug Type, 2019 & 2026

Figure 32:  Europe Anti-Fungal Drugs Market Value Share (%), by Drug Type, 2019

Figure 33:  Europe Anti-Fungal Drugs Market Value (US$ Bn), by Indication, 2019 & 2026

Figure 34:  Europe Anti-Fungal Drugs Market Value Share (%), by Indication, 2019

Figure 35:  Europe Anti-Fungal Drugs Market Value (US$ Bn), by Route of Administration, 2019 & 2026

Figure 36:  Europe Anti-Fungal Drugs Market Value Share (%), by Route of Administration, 2019

Figure 37:  Europe Anti-Fungal Drugs Market Value (US$ Bn), by Distribution Channel, 2019 & 2026

Figure 38:  Europe Anti-Fungal Drugs Market Value Share (%), by Distribution Channel, 2019

Figure 39:  Europe Anti-Fungal Drugs Market Value (US$ Bn), By Country/ Sub-region, 2019 & 2026

Figure 40:  Europe Anti-Fungal Drugs Market Value Share (%), By Country/ Sub-region, 2019

Figure 41:  Asia Pacific Anti-Fungal Drugs Market Value (US$ Bn), by Drug Type, 2019 & 2026

Figure 42:  Asia Pacific Anti-Fungal Drugs Market Value Share (%), by Drug Type, 2019

Figure 43:  Asia Pacific Anti-Fungal Drugs Market Value (US$ Bn), by Indication, 2019 & 2026

Figure 44:  Asia Pacific Anti-Fungal Drugs Market Value Share (%), by Indication, 2019

Figure 45:  Asia Pacific Anti-Fungal Drugs Market Value (US$ Bn), by Route of Administration, 2019 & 2026

Figure 46:  Asia Pacific Anti-Fungal Drugs Market Value Share (%), by Route of Administration, 2019

Figure 47:  Asia Pacific Anti-Fungal Drugs Market Value (US$ Bn), by Distribution Channel, 2019 & 2026

Figure 48:  Asia Pacific Anti-Fungal Drugs Market Value Share (%), by Distribution Channel, 2019

Figure 49:  Asia Pacific Anti-Fungal Drugs Market Value (US$ Bn), By Country/ Sub-region, 2019 & 2026

Figure 50:  Asia Pacific Anti-Fungal Drugs Market Value Share (%), By Country/ Sub-region, 2019

Figure 51:  Latin America Anti-Fungal Drugs Market Value (US$ Bn), by Drug Type, 2019 & 2026

Figure 52:  Latin America Anti-Fungal Drugs Market Value Share (%), by Drug Type, 2019

Figure 53:  Latin America Anti-Fungal Drugs Market Value (US$ Bn), by Indication, 2019 & 2026

Figure 54:  Latin America Anti-Fungal Drugs Market Value Share (%), by Indication, 2019

Figure 55:  Latin America Anti-Fungal Drugs Market Value (US$ Bn), by Route of Administration, 2019 & 2026

Figure 56:  Latin America Anti-Fungal Drugs Market Value Share (%), by Route of Administration, 2019

Figure 57:  Latin America Anti-Fungal Drugs Market Value (US$ Bn), by Distribution Channel, 2019 & 2026

Figure 58:  Latin America Anti-Fungal Drugs Market Value Share (%), by Distribution Channel, 2019

Figure 59:  Latin America Anti-Fungal Drugs Market Value (US$ Bn), By Country/ Sub-region, 2019 & 2026

Figure 60:  Latin America Anti-Fungal Drugs Market Value Share (%), By Country/ Sub-region, 2019

Figure 61:  Middle East & Africa Anti-Fungal Drugs Market Value (US$ Bn), by Drug Type, 2019 & 2026

Figure 62:  Middle East & Africa Anti-Fungal Drugs Market Value Share (%), by Drug Type, 2019

Figure 63:  Middle East & Africa Anti-Fungal Drugs Market Value (US$ Bn), by Indication, 2019 & 2026

Figure 64:  Middle East & Africa Anti-Fungal Drugs Market Value Share (%), by Indication, 2019

Figure 65:  Middle East & Africa Anti-Fungal Drugs Market Value (US$ Bn), by Route of Administration, 2019 & 2026

Figure 66:  Middle East & Africa Anti-Fungal Drugs Market Value Share (%), by Route of Administration, 2019

Figure 67:  Middle East & Africa Anti-Fungal Drugs Market Value (US$ Bn), by Distribution Channel, 2019 & 2026

Figure 68:  Middle East & Africa Anti-Fungal Drugs Market Value Share (%), by Distribution Channel, 2019

Figure 69:  Middle East & Africa Anti-Fungal Drugs Market Value (US$ Bn), By Country/ Sub-region, 2019 & 2026

Figure 70:  Middle East & Africa Anti-Fungal Drugs Market Value Share (%), By Country/ Sub-region, 2019

Figure 71:  Global Anti-Fungal Drugs Market Share (%), By Company, 2019

Table 1:  Global Anti-Fungal Drugs Market Revenue (US$ Bn) Forecast, by Drug Type, 2016–2027

Table 2:  Global Anti-Fungal Drugs Market Revenue (US$ Bn) Forecast, by Indication, 2016–2027

Table 3:  Global Anti-Fungal Drugs Market Revenue (US$ Bn) Forecast, by Route of Administration, 2016–2027

Table 4:  Global Anti-Fungal Drugs Market Revenue (US$ Bn) Forecast, by Distribution Channel, 2016–2027

Table 5:  Global Anti-Fungal Drugs Market Revenue (US$ Bn) Forecast, by Region, 2016-2027

Table 6:  North America Anti-Fungal Drugs Market Revenue (US$ Bn) Forecast, by Drug Type, 2016-2027

Table 7:  North America Anti-Fungal Drugs Market Revenue (US$ Bn) Forecast, by Indication, 2016-2027

Table 8:  North America Anti-Fungal Drugs Market Revenue (US$ Bn) Forecast, by Route of Administration, 2016-2027

Table 9:  North America Anti-Fungal Drugs Market Revenue (US$ Bn) Forecast, by Distribution Channel, 2016-2027

Table 10:  North America Anti-Fungal Drugs Market Revenue (US$ Bn) Forecast, By Country, 2016-2027

Table 11:  Europe Anti-Fungal Drugs Market Revenue (US$ Bn) Forecast, by Drug Type, 2016-2027

Table 12:  Europe Anti-Fungal Drugs Market Revenue (US$ Bn) Forecast, by Indication, 2016-2027

Table 13:  Europe Anti-Fungal Drugs Market Revenue (US$ Bn) Forecast, by Route of Administration, 2016-2027

Table 14:  Europe Anti-Fungal Drugs Market Revenue (US$ Bn) Forecast, by Distribution Channel, 2016-2027

Table 15:  Europe Anti-Fungal Drugs Market Revenue (US$ Bn) Forecast, By Country/ Sub-region, 2016-2027

Table 16:  Asia Pacific Anti-Fungal Drugs Market Revenue (US$ Bn) Forecast, by Drug Type, 2016-2027

Table 17:  Asia Pacific Anti-Fungal Drugs Market Revenue (US$ Bn) Forecast, by Indication, 2016-2027

Table 18:  Asia Pacific Anti-Fungal Drugs Market Revenue (US$ Bn) Forecast, by Route of Administration, 2016-2027

Table 19:  Asia Pacific Anti-Fungal Drugs Market Revenue (US$ Bn) Forecast, by Distribution Channel, 2016-2027

Table 20:  Asia Pacific Anti-Fungal Drugs Market Revenue (US$ Bn) Forecast, By Country/ Sub-region, 2016-2027

Table 21:  Latin America Anti-Fungal Drugs Market Revenue (US$ Bn) Forecast, by Drug Type, 2016-2027

Table 22:  Latin America Anti-Fungal Drugs Market Revenue (US$ Bn) Forecast, by Indication, 2016-2027

Table 23:  Latin America Anti-Fungal Drugs Market Revenue (US$ Bn) Forecast, by Route of Administration, 2016-2027

Table 24:  Latin America Anti-Fungal Drugs Market Revenue (US$ Bn) Forecast, by Distribution Channel, 2016-2027

Table 25:  Latin America Anti-Fungal Drugs Market Revenue (US$ Bn) Forecast, By Country/ Sub-region, 2016-2027

Table 26:  Middle East & Africa Anti-Fungal Drugs Market Revenue (US$ Bn) Forecast, by Drug Type, 2016-2027

Table 27:  Middle East & Africa Anti-Fungal Drugs Market Revenue (US$ Bn) Forecast, by Indication, 2016-2027

Table 28:  Middle East & Africa Anti-Fungal Drugs Market Revenue (US$ Bn) Forecast, by Route of Administration, 2016-2027

Table 29:  Middle East & Africa Anti-Fungal Drugs Market Revenue (US$ Bn) Forecast, by Distribution Channel, 2016-2027

Table 30:  Middle East & Africa Anti-Fungal Drugs Market Revenue (US$ Bn) Forecast, By Country/ Sub-region, 2016-2027

Antifungal Drugs Market Size, Share and Global Industry Trend Forecast till 2027
  • REPORT UPDATE
    IN PROCESS
  • 2019-2032
    (In Process)
  • 2023
    (In Process)
Multi-report Purchase Plan
    A Customized Plan Will be Created Based on the number of reports you wish to purchase